Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.45 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
| ▸ | HRH2 | P25021 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27166277 | 1.00 | APP (0.45) | APPKCNA5KCNH2SIGMAR1DRD4 | |
| SCHEMBL27268645 | 1.00 | APP (0.45) | APPKCNA5KCNH2SIGMAR1DRD4 | |
| SCHEMBL27166244 | 0.91 | APP (0.44) | APPSIGMAR1DRD4HRH2MEN1 | |
| SCHEMBL27166262 | 0.91 | APP (0.44) | APPSIGMAR1DRD4HRH2MEN1 | |
| SCHEMBL27166275 | 0.90 | SIGMAR1 (0.42) | APPSIGMAR1DRD4HRH2LTA4H | |
| SCHEMBL27166287 | 0.86 | SIGMAR1 (0.50) | SIGMAR1MEN1KMT2A | |
| SCHEMBL27166295 | 0.84 | SIGMAR1 (0.62) | SIGMAR1DRD4HRH2 | |
| SCHEMBL27268679 | 0.84 | SIGMAR1 (0.62) | SIGMAR1DRD4HRH2 | |
| SCHEMBL27166282 | 0.84 | SIGMAR1 (0.62) | SIGMAR1DRD4HRH2 | |
| SCHEMBL27166251 | 0.83 | LMNA (0.49) | SIGMAR1DRD4HRH2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584251-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024052549-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4335840-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2024-03-13 | — | — | EP | disclosed |